PG
GEM icon

Prostatis Group’s Goldman Sachs ActiveBeta Emerging Markets Equity ETF GEM Stock Holding History

Prostatis Group’s Portfolio GEM Stock Details GEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
29,922
-939
-3% -$46.5K 0.36% 56
2026
Q1 		$1.33M Sell
30,861
-1,944
-6% -$86.9K 0.34% 65
2025
Q4 		$1.37M Buy
32,805
+637
+2% +$26.5K 0.33% 64
2025
Q3 		$1.31M Sell
32,168
-371
-1% -$14.3K 0.33% 65
2025
Q2 		$1.21M Buy
32,539
+16,638
+105% +$571K 0.35% 64
2025
Q1 		$528K Buy
15,901
+4,259
+37% +$140K 0.17% 93
2024
Q4 		$372K Buy
+11,642
New +$395K 0.11% 117

Other funds holding GEM

Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SWM
SigFig Wealth Management San Francisco, California $3.77B AUM 15.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Betterment LLC
Betterment LLC New York $59.1B AUM 18.41% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $2.05B AUM 30.62% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Prostatis Group's GEM Position: Q2 2026 in Review

Prostatis Group reduced its Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) stake by 3% in Q2 2026, selling an estimated $46.5K and leaving 29,922 shares worth $1.56M. The position accounts for 0.36% of the portfolio, ranked #56.

Prostatis Group first reported a position in GEM in Q4 2024 and has held it in 7 quarters since. 203 funds tracked by Wall St. Rank hold GEM as of Q2 2026.

  • Prostatis Group held 29,922 shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF worth $1.56M as of Q2 2026.
  • Prostatis Group sold 939 Goldman Sachs ActiveBeta Emerging Markets Equity ETF shares in Q2 2026, an estimated $46.5K.
  • Goldman Sachs ActiveBeta Emerging Markets Equity ETF made up 0.36% of Prostatis Group's portfolio in Q2 2026, its #56 holding.
  • Prostatis Group first reported a position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • 203 funds tracked by Wall St. Rank held Goldman Sachs ActiveBeta Emerging Markets Equity ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.